We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 819 results
  1. Amiodarone and Dronedarone Causes Liver Injury with Distinctly Different Clinical Presentations

    Objective

    To describe hepatotoxicity due to amiodarone and dronedarone from the DILIN and the US FDA’s surveillance database.

    Methods

    Hepatotoxicity...

    Alexander Pop, Dina Halegoua-DeMarzio, ... Victor J. Navarro in Digestive Diseases and Sciences
    Article Open access 28 February 2024
  2. Dronedarone

    Article 09 March 2024
  3. Dronedarone

    Article 17 February 2024
  4. Effect of Prolonged Use of Dronedarone on Recurrence in Patients with Non-Paroxysmal Atrial Fibrillation After Radiofrequency Ablation (DORIS): Rationale and Design of a Randomized Multicenter, Double-Blinded Placebo-Controlled Trial

    Background

    Prolonged use of anti-arrhythmic drugs (AAD) beyond the post-ablation blanking period to maintain sinus rhythm has been adopted in clinical...

    Yizhang Wu, Fenghua Fan, ... Bing Yang in Cardiovascular Drugs and Therapy
    Article 08 May 2023
  5. Comparison of co-administration of amiodarone and rivaroxaban to co-administration of dronedarone and rivaroxaban for hemorrhage risks after atrial fibrillation ablation

    Purpose

    To investigate whether co-administration of antiarrhythmic dronedarone and anticoagulant rivaroxaban would increase the risks of hemorrhage...

    Peng Zhang, Mao**g Wang, ... Qing Zhao in Journal of Interventional Cardiac Electrophysiology
    Article Open access 20 January 2022
  6. Dronedarone

    Article 12 September 2020
  7. Amiodarone/dronedarone

    Article 19 September 2020
  8. Amiodarone/dronedarone

    Article 15 August 2020
  9. Dronedarone

    Article 29 February 2020
  10. Screening for drugs potentially interfering with MCT8-mediated T3 transport in vitro identifies dexamethasone and some commonly used drugs as inhibitors of MCT8 activity

    Background

    Monocarboxylate transporter 8 (MCT8) is the first thyroid hormone transporter that has been linked to a human disease. Besides genetic...

    C. Di Cosmo, G. De Marco, ... M. Tonacchera in Journal of Endocrinological Investigation
    Article 30 November 2021
  11. Safety and Effectiveness of Rivaroxaban in Combination with Various Antiarrhythmic Drugs in Patients with Non-Permanent Atrial Fibrillation

    Introduction

    Rivaroxaban reduces the risk of thromboembolism in atrial fibrillation (AF) patients, who often also receive antiarrhythmic drugs (AADs)...

    Wei-Ru Chiou, Chun-Che Huang, ... Ying-Hsiang Lee in American Journal of Cardiovascular Drugs
    Article 28 December 2020
Did you find what you were looking for? Share feedback.